Emerald Health Therapeutics, Inc. EMHTF
0.04 +0.04
Day range unavailable
52-week range unavailable
2Y -0.0055 (-11.96%)
News
Skye Bioscience concludes merger with Emerald Health Therapeutics and unveils goals for 2022 and 2023 
Skye Bioscience says Emerald Health Therapeutics shareholders approve integration plan of arrangement; gets regulatory approval to begin first-in-human clinical study 
Skye Bioscience signs agreement to merge with Emerald Health Therapeutics 
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals 
Emerald Health Therapeutics Announces Chief Financial Officer Transition 
Emerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q2 2021 Results - Earnings Call Transcript 
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update 
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET 
Emerald Health Therapeutics Hires VP Sales & Marketing 
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
Your note
Sign in to keep a note on EMHTF — it syncs with the Stock Master app.